Literature DB >> 20974534

Synthesis, cytotoxicity, and structure-activity relationship (SAR) studies of andrographolide analogues as anti-cancer agent.

Bimolendu Das1, Chinmay Chowdhury, Deepak Kumar, Rupashree Sen, Rajneeta Roy, Padma Das, Mitali Chatterjee.   

Abstract

A series of analogues of andrographolide, prepared through chemo-selective functionalization at C14 hydroxy, have been evaluated for in vitro cytotoxicities against human leukemic cell lines. Two of the analogues (6a, 9b) exhibited significant potency. Preliminary studies on structure-activity relationship (SAR) revealed that the α-alkylidene-γ-butyrolactone moiety of andrographolide played a major role in the activity profile. The structures of the analogues were established through spectroscopic and analytical data.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20974534     DOI: 10.1016/j.bmcl.2010.09.126

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  9 in total

1.  A quantitative chemical proteomics approach to profile the specific cellular targets of andrographolide, a promising anticancer agent that suppresses tumor metastasis.

Authors:  Jigang Wang; Xing Fei Tan; Van Sang Nguyen; Peng Yang; Jing Zhou; Mingming Gao; Zhengjun Li; Teck Kwang Lim; Yingke He; Chye Sun Ong; Yifei Lay; Jianbin Zhang; Guili Zhu; Siew-Li Lai; Dipanjana Ghosh; Yu Keung Mok; Han-Ming Shen; Qingsong Lin
Journal:  Mol Cell Proteomics       Date:  2014-01-20       Impact factor: 5.911

2.  Malabaricone-A induces a redox imbalance that mediates apoptosis in U937 cell line.

Authors:  Alak Manna; Piu Saha; Avijit Sarkar; Debanjan Mukhopadhyay; Ajay K Bauri; Deepak Kumar; Padma Das; Subrata Chattopadhyay; Mitali Chatterjee
Journal:  PLoS One       Date:  2012-05-10       Impact factor: 3.240

3.  Andrographolide Analogue Induces Apoptosis and Autophagy Mediated Cell Death in U937 Cells by Inhibition of PI3K/Akt/mTOR Pathway.

Authors:  Deepak Kumar; Bimolendu Das; Rupashree Sen; Priyanka Kundu; Alak Manna; Avijit Sarkar; Chinmay Chowdhury; Mitali Chatterjee; Padma Das
Journal:  PLoS One       Date:  2015-10-05       Impact factor: 3.240

4.  In situ imaging and proteome profiling indicate andrographolide is a highly promiscuous compound.

Authors:  Lin Li; Hadhi Wijaya; Sanjay Samanta; Yulin Lam; Shao Q Yao
Journal:  Sci Rep       Date:  2015-06-24       Impact factor: 4.379

5.  The anti-cancer activity of an andrographolide analogue functions through a GSK-3β-independent Wnt/β-catenin signaling pathway in colorectal cancer cells.

Authors:  Somrudee Reabroi; Rungnapha Saeeng; Nittaya Boonmuen; Teerapich Kasemsuk; Witchuda Saengsawang; Kanoknetr Suksen; Weiming Zhu; Pawinee Piyachaturawat; Arthit Chairoungdua
Journal:  Sci Rep       Date:  2018-05-21       Impact factor: 4.379

6.  Low Expression of ZNF154 is Related to Poor Prognosis in Gastric Cancer.

Authors:  Jinsong He; Jing Huang; Guo Tang; Pan Wang; Ming He; Shoujiang Wei
Journal:  Cancer Manag Res       Date:  2022-02-17       Impact factor: 3.989

7.  Cytotoxic activity and apoptosis-inducing potential of di-spiropyrrolidino and di-spiropyrrolizidino oxindole andrographolide derivatives.

Authors:  Sumit Kumar Dey; Dipayan Bose; Abhijit Hazra; Subhendu Naskar; Abhishek Nandy; Rudra Narayan Munda; Subhadip Das; Nabanita Chatterjee; Nirup Bikash Mondal; Sukdeb Banerjee; Krishna Das Saha
Journal:  PLoS One       Date:  2013-03-05       Impact factor: 3.240

8.  Apoptotic and autophagic effects of Sesbania grandiflora flowers in human leukemic cells.

Authors:  Rajneeta Roy; Deepak Kumar; Biswajit Chakraborty; Chinmay Chowdhury; Padma Das
Journal:  PLoS One       Date:  2013-08-13       Impact factor: 3.240

9.  Mediation of the malignant biological characteristics of gastric cancer cells by the methylated CpG islands in RNF180 DNA promoter.

Authors:  Jingyu Deng; Jiangtao Guo; Xiaofan Guo; Yachao Hou; Xingming Xie; Changyu Sun; Rupeng Zhang; Xiaohua Yu; Han Liang
Journal:  Oncotarget       Date:  2016-07-12
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.